Literature DB >> 28710530

Proteomic characterisation reveals active Wnt-signalling by human multipotent stromal cells as a key regulator of beta cell survival and proliferation.

Miljan Kuljanin1, Gillian I Bell2, Stephen E Sherman2,3, Gilles A Lajoie4, David A Hess5,6.   

Abstract

AIMS/HYPOTHESIS: Novel strategies to stimulate the expansion of beta cell mass in situ are warranted for diabetes therapy. The aim of this study was to elucidate the secretome of human bone marrow (BM)-derived multipotent stromal cells (MSCs) with documented islet regenerative paracrine function. We hypothesised that regenerative MSCs will secrete a unique combination of protein factors that augment islet regeneration.
METHODS: Human BM-derived MSCs were examined for glucose-lowering capacity after transplantation into streptozotocin-treated NOD/severe combined immunodeficiency (SCID) mice and segregated into samples with regenerative (MSCR) vs nonregenerative (MSCNR) capacity. Secreted proteins associated with islet regenerative function were identified using stable isotope labelling with amino acids in cell culture (SILAC)-based quantitative proteomics. To functionally validate the importance of active Wnt signalling, we stimulated the Wnt-signalling pathway in MSCNR samples during ex vivo expansion using glycogen synthase kinase 3 (GSK3) inhibition (CHIR99201), and the conditioned culture media (CM) generated was tested for the capacity to support cultured human islet cell survival and proliferation in vitro.
RESULTS: MSCR showed increased secretion of proteins associated with cell growth, matrix remodelling, immunosuppressive and proangiogenic properties. In contrast, MSCNR uniquely secreted proteins known to promote inflammation and negatively regulate angiogenesis. Most notably, MSCR maintained Wnt signalling via Wnt5A/B (~2.5-fold increase) autocrine activity during ex vivo culture, while MSCNR repressed Wnt signalling via Dickkopf-related protein (DKK)1 (~2.5-fold increase) and DKK3 secretion. Inhibition of GSK3 activity in MSCNR samples increased the accumulation of nuclear β-catenin and generated CM that augmented beta cell survival (13% increases) and proliferation when exposed to cultured human islets. CONCLUSIONS/
INTERPRETATION: Maintenance of active Wnt signalling within human MSCs promotes the secretion of matricellular and proangiogenic proteins that formulate a niche for islet regeneration.

Entities:  

Keywords:  Angiogenesis; Diabetes; Inflammation; Islets; Mass spectrometry; Multipotent stromal cells; Proteomics; Wnt signalling

Mesh:

Year:  2017        PMID: 28710530     DOI: 10.1007/s00125-017-4355-7

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  47 in total

Review 1.  Wnt signaling: multiple pathways, multiple receptors, and multiple transcription factors.

Authors:  Michael D Gordon; Roel Nusse
Journal:  J Biol Chem       Date:  2006-06-22       Impact factor: 5.157

2.  Inhibition of GSK3 promotes replication and survival of pancreatic beta cells.

Authors:  Rainer Mussmann; Marcus Geese; Friedrich Harder; Simone Kegel; Uwe Andag; Alexander Lomow; Ulrike Burk; Daria Onichtchouk; Cord Dohrmann; Matthias Austen
Journal:  J Biol Chem       Date:  2007-01-22       Impact factor: 5.157

3.  Canonical notch signaling functions as a commitment switch in the epidermal lineage.

Authors:  Cédric Blanpain; William E Lowry; H Amalia Pasolli; Elaine Fuchs
Journal:  Genes Dev       Date:  2006-11-01       Impact factor: 11.361

4.  Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury.

Authors:  Ruenn Chai Lai; Fatih Arslan; May May Lee; Newman Siu Kwan Sze; Andre Choo; Tian Sheng Chen; Manuel Salto-Tellez; Leo Timmers; Chuen Neng Lee; Reida Menshawe El Oakley; Gerard Pasterkamp; Dominique P V de Kleijn; Sai Kiang Lim
Journal:  Stem Cell Res       Date:  2010-01-04       Impact factor: 2.020

5.  Pancreatic islet production of vascular endothelial growth factor--a is essential for islet vascularization, revascularization, and function.

Authors:  Marcela Brissova; Alena Shostak; Masakazu Shiota; Peter O Wiebe; Greg Poffenberger; Jeannelle Kantz; Zhongyi Chen; Chad Carr; W Gray Jerome; Jin Chen; H Scott Baldwin; Wendell Nicholson; David M Bader; Thomas Jetton; Maureen Gannon; Alvin C Powers
Journal:  Diabetes       Date:  2006-11       Impact factor: 9.461

6.  Angiogenic effects of stromal cell-derived factor-1 (SDF-1/CXCL12) variants in vitro and the in vivo expressions of CXCL12 variants and CXCR4 in human critical leg ischemia.

Authors:  Teik K Ho; Janice Tsui; Shiwen Xu; Patricia Leoni; David J Abraham; Daryll M Baker
Journal:  J Vasc Surg       Date:  2010-03       Impact factor: 4.268

7.  Mesenchymal stem cells protect NOD mice from diabetes by inducing regulatory T cells.

Authors:  A M Madec; R Mallone; G Afonso; E Abou Mrad; A Mesnier; A Eljaafari; C Thivolet
Journal:  Diabetologia       Date:  2009-05-07       Impact factor: 10.122

Review 8.  Roles of main pro- and anti-angiogenic factors in tumor angiogenesis.

Authors:  Zhi Huang; Shi-Deng Bao
Journal:  World J Gastroenterol       Date:  2004-02-15       Impact factor: 5.742

9.  Generation of insulin-producing cells from human bone marrow mesenchymal stem cells by genetic manipulation.

Authors:  Ohad Karnieli; Yael Izhar-Prato; Shlomo Bulvik; Shimon Efrat
Journal:  Stem Cells       Date:  2007-07-05       Impact factor: 6.277

Review 10.  Biomaterials as carrier, barrier and reactor for cell-based regenerative medicine.

Authors:  Chunxiao Qi; Xiaojun Yan; Chenyu Huang; Alexander Melerzanov; Yanan Du
Journal:  Protein Cell       Date:  2015-06-19       Impact factor: 14.870

View more
  7 in total

1.  Direct comparison of the abilities of bone marrow mesenchymal versus hematopoietic stem cells to reverse hyperglycemia in diabetic NOD.SCID mice.

Authors:  Edith J Arany; Muhammad Waseem; Brenda J Strutt; Astrid Chamson-Reig; Adam Bernardo; Elizabeth Eng; David J Hill
Journal:  Islets       Date:  2018-08-15       Impact factor: 2.694

2.  Dickkopf Homolog 3 (DKK3) as a Prognostic Marker in Lupus Nephritis: A Prospective Monocentric Experience.

Authors:  Savino Sciascia; Alice Barinotti; Massimo Radin; Irene Cecchi; Elisa Menegatti; Edoardo Terzolo; Daniela Rossi; Simone Baldovino; Roberta Fenoglio; Dario Roccatello
Journal:  J Clin Med       Date:  2022-05-25       Impact factor: 4.964

Review 3.  Mesenchymal Stem Cells: A Trump Card for the Treatment of Diabetes?

Authors:  Elisabetta Donzelli; Arianna Scuteri
Journal:  Biomedicines       Date:  2020-05-06

Review 4.  The Role of Notch and Wnt Signaling in MSC Communication in Normal and Leukemic Bone Marrow Niche.

Authors:  Paul Takam Kamga; Riccardo Bazzoni; Giada Dal Collo; Adriana Cassaro; Ilaria Tanasi; Anna Russignan; Cristina Tecchio; Mauro Krampera
Journal:  Front Cell Dev Biol       Date:  2021-01-08

5.  Elevation of Hemoglobin A1c Increases the Atherosclerotic Plaque Vulnerability and the Visit-to-Visit Variability of Lipid Profiles in Patients Who Underwent Elective Percutaneous Coronary Intervention.

Authors:  Duanbin Li; Ya Li; Cao Wang; Hangpan Jiang; Liding Zhao; Xulin Hong; Maoning Lin; Yi Luan; Xiaohua Shen; Zhaoyang Chen; Wenbin Zhang
Journal:  Front Cardiovasc Med       Date:  2022-02-03

Review 6.  The complex role of Wnt ligands in type 2 diabetes mellitus and related complications.

Authors:  Xiaobo Nie; Xiaoyun Wei; Han Ma; Lili Fan; Wei-Dong Chen
Journal:  J Cell Mol Med       Date:  2021-05-27       Impact factor: 5.310

Review 7.  Regulation of pathophysiological and tissue regenerative functions of MSCs mediated via the WNT signaling pathway (Review).

Authors:  Qingtao Zhang; Jian Yu; Qiuqiu Chen; Honghai Yan; Hongjiang Du; Wenjing Luo
Journal:  Mol Med Rep       Date:  2021-07-19       Impact factor: 2.952

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.